Join our daily newsletter At The Bell to receive exclusive market insights
The ASX has been down 1.5% at 7,739 points this morning.
There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.
Staples and Health Care are the only sectors in positive territory so far.
In company news, Mesoblast (ASX:MSB) has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.
Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.
And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.
More market news
Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
